Mandate

Vinge advises Santander Consumer Finance in connection with its acquisition of Athlon Sweden AB

Vinge advises Santander Consumer Finance in connection with its acquisition of all shares in Athlon Sweden AB, which is part of Mercedes-Benz Mobility.

Athlon Sweden AB, operating in the field of car leasing and fleet management, is headquartered in Malmö, with a sales presence also in Stockholm. The company has demonstrated substantial growth over the last five years and currently manages a portfolio of 5,200 cars and vans, positioning itself as the ninth-largest player in the Swedish market.

The completion of the transaction is subject to customary regulatory approvals.

Vinge´s team consisted of Christina Kokko together with Isabelle Wållgren, Robin Fagerström (M&A), Christoffer Nordin, Sam Fakhraie Ardekani (Commercial Agreements), Lisa Hörnqvist (GDPR/IT), Emma-Stuart Beck, Caroline Krassén, Elias Bohlin (Financial Services), David Flodin (Banking and Finance), Jonna Bondemark (Insurance Regulatory), Axel Lennartsson (IPR), Madelene Andersson (Real Estate), Gulestan Ali (Employment), Fanny Askelöf (Transaction Support Specialist), and Emma Emsjö (Project Assistant).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025